ATE528003T1 - Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen - Google Patents

Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen

Info

Publication number
ATE528003T1
ATE528003T1 AT03771445T AT03771445T ATE528003T1 AT E528003 T1 ATE528003 T1 AT E528003T1 AT 03771445 T AT03771445 T AT 03771445T AT 03771445 T AT03771445 T AT 03771445T AT E528003 T1 ATE528003 T1 AT E528003T1
Authority
AT
Austria
Prior art keywords
liquid preparations
aqueous
light
stabilized
aqueous liquid
Prior art date
Application number
AT03771445T
Other languages
English (en)
Inventor
Masayo Higashiyama
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31184981&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE528003(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE528003T1 publication Critical patent/ATE528003T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT03771445T 2002-07-31 2003-07-30 Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen ATE528003T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002223804 2002-07-31
PCT/JP2003/009713 WO2004011001A1 (ja) 2002-07-31 2003-07-30 水性液剤および光安定化された水性液剤

Publications (1)

Publication Number Publication Date
ATE528003T1 true ATE528003T1 (de) 2011-10-15

Family

ID=31184981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03771445T ATE528003T1 (de) 2002-07-31 2003-07-30 Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen

Country Status (9)

Country Link
US (3) US8784789B2 (de)
EP (1) EP1525884B1 (de)
JP (1) JP3631748B2 (de)
KR (1) KR101016595B1 (de)
CN (1) CN1293880C (de)
AT (1) ATE528003T1 (de)
AU (1) AU2003252746A1 (de)
ES (1) ES2371340T3 (de)
WO (1) WO2004011001A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4739340B2 (ja) * 2005-07-22 2011-08-03 田辺三菱製薬株式会社 口腔内速崩壊性錠
BR112013008244A8 (pt) * 2010-10-06 2018-02-14 Bausch & Lomb composições de bepotastina
BR112013017183A2 (pt) * 2011-01-04 2017-07-25 Bausch & Lomb composições de bepostatina
CN104119314B (zh) * 2013-04-23 2018-01-12 重庆华邦制药有限公司 一种稳定的苯磺酸贝他斯汀晶体及其制备方法
CN106038480B (zh) * 2015-04-16 2019-02-22 江苏恒瑞医药股份有限公司 一种光稳定的水性液体制剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4929618A (en) * 1988-03-25 1990-05-29 Ube Industries, Ltd. Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
JPH0418015A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk 安定なフマル酸クレマスチン水溶液
CA2038066A1 (en) * 1990-08-09 1992-02-10 Hiroshi Fukumi (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma
JP3225976B2 (ja) * 1992-05-29 2001-11-05 キヤノン株式会社 カラー画像形成装置
JP3021312B2 (ja) 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
NO950970L (no) * 1994-03-15 1995-09-18 Senju Pharma Co Fremgangsmåte for stabilisering av pranoprofen og stabile væskepreparater av pranoprofen
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
JP2929274B2 (ja) 1996-08-15 1999-08-03 エーザイ株式会社 点眼液の光安定化方法
TW486475B (en) * 1996-12-26 2002-05-11 Ube Industries Acid addition salt of optically active piperidine compound and process for preparing the same
JP3107784B2 (ja) * 1996-12-26 2000-11-13 宇部興産株式会社 光学活性ピペリジン誘導体の酸付加塩及びその製法
JP3361713B2 (ja) * 1997-02-26 2003-01-07 大八化学工業株式会社 トリブロモネオペンチルリン酸クロロアルキルエステルの製造方法
DE69818675T2 (de) * 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
JPH11228404A (ja) 1997-12-11 1999-08-24 Senju Pharmaceut Co Ltd 安定な水性点眼剤
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6369001B1 (en) * 1999-08-11 2002-04-09 Monsanto Technology, Llc Microemulsion coformulation of a graminicide and a water-soluble herbicide
PT1225898E (pt) * 1999-11-01 2003-10-31 Alcon Inc Composicoes farmaceuticas contendo um farmaco antibiotico de fluoroquinolona e goma xantana
JP2001261563A (ja) 2000-03-16 2001-09-26 Cci Corp マトリックスメタロプロテアーゼ産生抑制剤
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP3909998B2 (ja) 2000-03-22 2007-04-25 田辺製薬株式会社 経口投与製剤
ES2305065T3 (es) 2000-04-24 2008-11-01 Daiichi Sankyo Company, Limited Preparacion liquida estable que contiene sitafloxacina.
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CN1293867C (zh) * 2001-05-25 2007-01-10 爱诗爱诗制药株式会社 药物复合制剂
EP2279005A1 (de) 2008-05-19 2011-02-02 Alcon Research, Ltd. Pharmazeutische zusammensetzungen mit carboxyvinylpolymeren und povidonpolymeren

Also Published As

Publication number Publication date
AU2003252746A1 (en) 2004-02-16
EP1525884A1 (de) 2005-04-27
CN1612734A (zh) 2005-05-04
US8784789B2 (en) 2014-07-22
KR101016595B1 (ko) 2011-02-22
WO2004011001A1 (ja) 2004-02-05
KR20050025137A (ko) 2005-03-11
US20150031724A1 (en) 2015-01-29
JPWO2004011001A1 (ja) 2005-11-24
US20120322825A1 (en) 2012-12-20
US9849121B2 (en) 2017-12-26
JP3631748B2 (ja) 2005-03-23
US20050107429A1 (en) 2005-05-19
EP1525884B1 (de) 2011-10-12
US8883825B2 (en) 2014-11-11
EP1525884A4 (de) 2007-10-31
ES2371340T3 (es) 2011-12-30
CN1293880C (zh) 2007-01-10

Similar Documents

Publication Publication Date Title
MXPA05001841A (es) Formulacion de anticuerpos humanos para tratar trastornos asociados con tnfa.
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
BR0109650A (pt) 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
NO20050497L (no) Anvendelse av CETP inhibitorer og eventuelt HMG COA reduserbare inhibitorer og/eller antihypertensiva
ATE290877T1 (de) Stabilisierte insulin-zubereitungen
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
NO20054018L (no) Intranasal formulering av rotigotin
NO20034751D0 (no) Antranilsyreamider, deres fremstilling og anvendelse samt preparater
AR030245A1 (es) Composiciones de gel que contienen metronidazol
HUP0301512A2 (hu) Gyomor-bél csatornában fellépő kötőszöveti váz tumorok kezelése
ATE427747T1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE60314441D1 (de) Analyse pharmazeutischer löslichkeit und stabilität
NL1024676A1 (nl) HIV integrase-remmers, farmaceutische preparaten en methoden voor het gebruik daarvan.
ATE528003T1 (de) Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
PL1663141T3 (pl) Wodny roztwór farmaceutyczny zawierający oksymetazolinę i/lub ksylometazolinę
UY27373A1 (es) Formulaciones de interferón beta-humano
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
MY134059A (en) Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
HUP0202832A2 (hu) Új pirimidin-2,4,6-trion-származékok, alkalmazásuk, valamint az e vegyületeket tartalmazó gyógyászati készítmények
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties